Blog
Promising Progress: Rare Spine Cancer Shows Positive Response in Clinical Trial at Providence Saint John’s Health Center’s Cancer Institute
by Guest Author
SANTA MONICA (Dec. 4, 2023) — Promising results of a pilot study at Providence Saint John’s Health Center to treat a rare form of cancer of the spine and skull base were published today by the journal Clinical Cancer Research.
Nature-Themed Psychedelic Therapy for Alcohol Addiction: Promising Findings Using Renowned Filmmaker’s Videos
by Guest Author
Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.
Glioblastoma Awareness Day: Confronting the Challenges of a Devastating Brain Tumor
by Brianna Rauchman
Today, July 19, 2023, marks the observance of Glioblastoma Awareness Day. Glioblastoma (GBM) is an infamous form of brain cancer, presenting immense difficulties in its treatment.
Trial Results Offer Hope for Improved rGBM Survival Outcomes
by Guest Author
Expert neuro-oncologist Santosh Kesari, MD, PhD, Director of Neuro-oncology at Pacific Neuroscience Institute and Chair and Professor of the Department of Translational Neurosciences at Saint John’s Cancer Institute, published the results from a phase 2 clinical trial for recurrent glioblastoma (rGBM), offering hope for improved survival outcomes and pushing novel treatment one step closer to FDA approval.
PNI Foundation VP Melissa Coleman Builds Up the Neurosciences
by Amelia Garrison
With nearly two decades of nonprofit management and fundraising experience, Melissa B. Coleman, Esq, Vice President of the PNI Foundation (PNIF), is an expert at building programmatic research teams in support of neurosciences.
PNI Founders’ Message 2023
by Daniel F. Kelly
At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.
Clinical Trial Results for World’s First Glioblastoma Vaccine
by Amelia Garrison
Renowned neuro-oncologist Santosh Kesari, MD, PhD, is one of the authors of a phase 3 trial that found that the use of an autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) added to the standard of care (SOC) treatment of both newly diagnosed glioblastoma and recurrent glioblastoma...
Stem Cell Therapy and Brain Health: The Future Is Now
by PNI Experts
Clinical trials using stem cells have shown promising early results as cellular therapies in regenerative medicine, as well as in potential anti-cancer applications. Read more about Dr. Achal Singh Achrol's neurosurgery clinical trials program and this leading-edge technology.
Trials for Patients with Brain Tumors and Difficult Diseases
by Guest Author
Santosh Kesari, MD, PhD, of Pacific Neuroscience Institute is the principal investigator for more than a dozen clinical trials, of which 8 are brain tumor-related. Dr. Kesari is Director of Neuro-oncology at PNI, and Chair and Professor of the Department of Translational Neurosciences at Saint John’s Cancer Institute. He is ranked among the top 1 percent of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd, and is an internationally recognized scientist and clinician.
VR Games Could Offer Hope for Delaying Dementia
by Guest Author
Virtual reality games that combine physical activity and brain-training may help slow cognitive decline in older adults, research at Pacific Neuroscience Institute suggests.
Last updated: June 14th, 2022